SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999; 70: 10161024.
  • 2
    El-Khairy L, Vollset SE, Refsum H, Ueland PM. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem 2003; 49: 113120.
  • 3
    Elshorbagy AK, Nurk E, Gjesdal CG et al. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr 2008; 88: 738746.
  • 4
    Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Molecular and Metabolic Bases of Inherited Disease. McGraw-Hill: New York, 1995, pp 12791327.
  • 5
    Brenton DP, Dow CJ, James JI, Hay RL, Wynne-Davies R. Homocystinuria and Marfan's syndrome. A comparison. J Bone Joint Surg Br 1972; 54: 277298.
  • 6
    Gibson JB, Carson NA, Neill DW. Pathological Findings in Homocystinuria. J Clin Pathol 1964; 17: 427437.
  • 7
    Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Val D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill: New York, 1995, pp 31293149.
  • 8
    Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Val D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill: New York, 1995, pp 31113128.
  • 9
    Kraus JP, Kožich V. Cystathionine β synthase and its deficiency. In: Carmel R, Jacobsen DW (eds). Homocysteine in Health and Disease. Cambridge University Press: Cambridge, 2001, pp 223244.
  • 10
    Blouet C, Mariotti F, Azzout-Marniche D et al. Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. Free Radic Biol Med 2007; 42: 10891097.
  • 11
    Fulghesu AM, Ciampelli M, Muzj G et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 11281135.
  • 12
    Stipanuk MH, Dominy JE Jr, Lee JI, Coloso RM. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr 2006; 136: 1652S1659S.
  • 13
    Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489492.
  • 14
    Whitfield JB. γ glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263355.
  • 15
    Barrios R, Shi ZZ, Kala SV et al. Oxygen-induced pulmonary injury in γ-glutamyl transpeptidase-deficient mice. Lung 2001; 179: 319330.
  • 16
    Lieberman MW, Wiseman AL, Shi ZZ et al. Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 79237926.
  • 17
    Hammond JW, Potter M, Sim KG, Wilcken B. Reduced glutathione, γ-glutamylcysteine, cysteine and γ-glutamylglutamine in γ-glutamyltransferase deficiency. J Inherit Metab Dis 1999; 22: 235239.
  • 18
    Sedda V, De Chiara B, Parolini M et al. Plasma glutathione levels are independently associated with γ-glutamyltransferase activity in subjects with cardiovascular risk factors. Free Radic Res 2008; 42: 135141.
  • 19
    Iwasaki T, Yoneda M, Kawasaki S et al. Hepatic fat content-independent association of the serum level of γ-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Diabetes Res Clin Pract 2008; 79: e13e14.
  • 20
    Lawlor DA, Sattar N, Smith GD, Ebrahim S. The associations of physical activity and adiposity with alanine aminotransferase and γ-glutamyltransferase. Am J Epidemiol 2005; 161: 10811088.
  • 21
    Lee DH, Blomhoff R, Jacobs DR Jr. Is serum γ glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535539.
  • 22
    Giral P, Jacob N, Dourmap C et al. Elevated γ-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 587593.
  • 23
    Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 17751781.
  • 24
    Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263271.
  • 25
    Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of γ-glutamyltransferase. Am J Epidemiol 1990; 132: 318326.
  • 26
    Lee DS, Evans JC, Robins SJ et al. γ glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007; 27: 127133.
  • 27
    Stranges S, Dorn JM, Muti P et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004; 39: 754763.
  • 28
    Baines M, Kredan MB, Davison A et al. The association between cysteine, bone turnover, and low bone mass. Calcif Tissue Int 2007; 81: 450454.
  • 29
    Akahoshi N, Kobayashi C, Ishizaki Y et al. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine β-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet 2008; 17: 19942005.
  • 30
    Tozer RG, Tai P, Falconer W et al. Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal 2008; 10: 395402.
  • 31
    Stipanuk MH, Londono M, Lee JI, Hu M, Yu AF. Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J Nutr 2002; 132: 33693378.
  • 32
    Malloy VL, Krajcik RA, Bailey SJ et al. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 2006; 5: 305314.
  • 33
    Roizen NJ, Patterson D. Down's syndrome. Lancet 2003; 361: 12811289.
  • 34
    Allison DB, Gomez JE, Heshka S et al. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord 1995; 19: 858861.
  • 35
    Fernhall B, Figueroa A, Collier S et al. Resting metabolic rate is not reduced in obese adults with Down syndrome. Ment Retard 2005; 43: 391400.
  • 36
    Pogribna M, Melnyk S, Pogribny I et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 2001; 69: 8895.
  • 37
    Lejeune J, Rethore MO, de Blois MC et al. [Amino acids and trisomy 21]. Ann Genet 1992; 35: 813.
  • 38
    Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on γ-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 1998; 22: 941944.